Latest news
Heart attack: GLP-1 drug tirzepatide may cut risk by 33% - Medical News TodayMedical News Today · Mon, 10 Aug 2026 15:26:05 GMTTirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes - News-MedicalNews-Medical · Mon, 10 Aug 2026 06:17:00 GMTPublic Comment Closes on the FDA Plan to Permanently Bar Bulk Compounding of Semaglutide and Tirzepatide - Medical DailyMedical Daily · Fri, 31 Jul 2026 12:50:09 GMT